NXTS compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

NXTSNexentis Technologies Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

NXTSNexentis Technologies Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NXTS 0

None

Shared 0

No disclosed counterparties: NXTS.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Role chip = supplier or customerSource: SEC EDGAR

NXTSNexentis Technologies Inc.

0.62▲+9.05%· post 0.55· delayed

Mkt cap$826,946Revenue$2,000Q3 FY25Revenue—

LLYELI Lilly & Co

1,417.89▲+0.60%· post 1,416.43· delayed

After hoursNov 4 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 4 '26delayed

NXTSNexentis Technologies Inc.

LLYELI Lilly & Co

0.62▲+9.05%post 0.55delayed

Price

1,417.89▲+0.60%post 1,416.43delayed

$826,946

Mkt cap

$1.3T

Q3 FY25$2,000

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

NXTS0.62▲+9.05%vsLLY1,417.89▲+0.60%After hoursNov 4 '26delayed